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previous Editor’s Pages have addressed the value of inte-
rating the flow of new information to physicians (1). The
ationale was presented for coordinating the work of the
ublication medium for peer-reviewed original research
Journal of the American College of Cardiology [JACC]) with
he organ of rapid online dissemination of information
Cardiosource) and the presentation venue for recently
enerated data (Annual Scientific Sessions). In the process
f integrating this flow, we initiated a new venture with the
nnual Scientific Sessions (ACC.06) this year. Our early
xperience with this venture has provided some interesting
nsight into the status of brief research abstracts and their
elation to full detailed manuscripts.
Early in the planning of ACC.06, discussions were held
etween the Program Chairs and JACC editors about ways
o interact that would benefit each venue as well as both
eaders and attendees. We reasoned that rapid publication
f the manuscripts of the highest rated abstracts would be of
alue to our readers. In addition, expedited review/
ublication of papers should be enormously appealing to
uthors and ultimately attract the highest quality research to
oth the Scientific Sessions and JACC. Therefore, we
greed that the Chair identify the three to five highest rated
bstracts from each abstract category to whom JACC would
ffer expedited processing of the completed manuscript. Of
he 1,500 abstracts received, rapid review was awarded to
0. Each selected abstract had achieved the highest grades
rom the panel of reviewers a decision with which the
ategory Chair was in concurrence. Our anticipation was
hat the papers resulting from these abstracts would receive
omparable evaluations.
At the time of this writing approximately 20 full manu-
cripts have been submitted in response to our offer. The
anuscripts have spanned the spectrum of categories and have
een generally consistent with the conclusions of the abstract.
e have thus far completed the review process for three-
uarters of these papers. Approximately 50% have been re-
ected, 25% accepted for publication, and 25% await a final
ecision. Of interest, there appears to be somewhat less
iscordance between the critiques of the individual reviewers
or these manuscripts than there has been for our regular
ubmissions (which average nearly 40% disagreement).
My initial reaction to the fate of these manuscripts upon
eer review was one of surprise. The acceptance rate of 25%,
hich may ultimately reach 50%, is certainly superior to our
sual acceptance rate of about 15%. In addition, rejection aertainly does not mean that the manuscripts are not of
ood quality; our page limitations require that we decline
any papers of considerable merit. However, I had antici-
ated that these papers would fare better. After all, they
ere the finished product of abstracts that had been judged
o be among the very best of a large number of competitive
ubmissions. Clearly, the full manuscripts did not receive
he same evaluations as the abstracts.
There are, of course, a number of possible explanations
or the discordance between the high grades given to the
bstracts and the lower priority scores assigned to the
anuscripts. It is likely that the criteria applied to grading
n abstract are different from those used for a manuscript. I
elieve that abstract presentations are often seen as prelim-
nary, and so the novelty and/or potential importance of the
dea is accorded greater importance than the data support-
ng it. This is particularly true given the limited words
vailable to describe methods, results, and conclusions in an
bstract. Since abstracts are given in the form of oral or
oster presentations, they may be accorded value as vehicles
o engender new concepts or lively debate. Abstract review-
rs may well reason that any problems with the work will be
xposed during the presentation. Conversely, abstracts that
pply elegant and complex methodology to systematically
rovide data regarding previously studied questions may be
iewed as lacking novelty or excitement.
As I see it, however, the most important factor in the
isparity in grading is that abstracts are just that, limited
ummaries of a research study. By virtue of the word
imitation it is nearly impossible to adequately describe
ethods, results, and analysis. Raw data are rarely available
or review, and description of statistics is scant if at all. The
hought that a research study could be adequately contained
n a dozen or so sentences is so preposterous that no
eviewer has any such expectations or demands. Therefore,
t is not unusual when an abstract accepted for presentation
s found to have significant flaws. However, even a 10
inute oral presentation may fail to reveal major problems
ith a study. It should thus not be surprising that abstract
resentations that are well received sometimes fail to pass
he intense scrutiny of peer review as full manuscripts. The
otential for such occurrences is amplified by the competi-
ion for the limited pages of top-tier medical journals, where
ven very good papers fail to achieve sufficient priority for
ublication. Nonetheless, it is a bit disconcerting that such
large percentage of the most highly graded abstracts fail to
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anuscripts.
The major issue I have with all of this is that abstracts are
ften portrayed as more than they actually are. As pointed out
n an earlier piece on late-breaking clinical trials (2), abstract
resentations are often featured in the publicity surrounding
ational meetings. They are frequently reported online with
reat fanfare and detail, and often with the air of finality that
he data are accurate and that the analysis is correct. Data from
bstracts are not uncommonly incorporated into bibliographies
nd into the presentations of speakers at medical meetings. In
act, it has been suggested that the detailed reporting of an
bstract presentation with the inclusion of data slides should
reclude a full-length manuscript from acceptance due to
duplicate publication.” In my opinion, all of this belies the
eality of the limitations inherent in abstracts, and of their very
reliminary nature. Only after a complete manuscript passes
he scrutiny of peer review and appears in writing for all to
valuate should it be accepted as suitable scientific information.
Medical meetings, particularly the national and interna-
ional scientific sessions, are an important component in the
ow of information. Abstract presentations, as a key ele-
ent of these meetings, are an important component of new
2nowledge. As such, I will look forward to observing as well
s delivering such presentations in the future. We will also
ontinue our efforts to integrate the knowledge contained in
he meetings with that of the Journal. I persist in thinking
hat it is highly likely that much of the important new
esearch data published in the future will emerge from
bstracts and that these will often be identified by high
rades. However, our recent experience again emphasizes
he limitation of abstracts in providing new and important
ata. A cliché regarding clinical services and medical records
tates that “if it isn’t documented in the chart, it didn’t
appen.” The same might be said of abstracts and full-
ength peer-reviewed manuscripts.
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